NCT06687616View on ClinicalTrials.gov

RCT of VR Therapy for IBS

NAActive, not recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

February 26, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
IBS - Irritable Bowel Syndrome
Interventions
DEVICE

SynerGI

Standardized 8-week CBT program, used for 20-30 minutes per week

DEVICE

Sham VR

Distraction-based VR program with 2D nature videos to be used for 8 weeks, 2-2 times a week for 10 minutes

Trial Locations (2)

44195

Cleveland Clinic, Cleveland

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
collaborator

The Cleveland Clinic

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Christopher Almario

OTHER

NCT06687616 - RCT of VR Therapy for IBS | Biotech Hunter | Biotech Hunter